On January 3, 2018 FUJIFILM Diosynth Biotechnologies, a leading global biologics Contract Development and Manufacturing Organization (CDMO), reported that Martin Meeson, President and COO of FUJIFILM Diosynth Biotechnologies U.S.A., is scheduled to present at EBD’s Biotech Showcase 2018 event during the 36th Annual J.P. Morgan Healthcare conference week in San Francisco, California (Press release, Fujifilm, JAN 3, 2018, View Source [SID1234522852]). The presentation is scheduled to take place Tuesday, Jan. 9, 2018 at 3:00 PM PST. The presentation will be part of the Yosemite -B Track (Ballroom Level).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Meeson’s presentation will focus on FUJIFILM Diosynth Biotechnologies’ investment strategies to support the growth and expansion required to meet the global demands in the delivery of biologics, gene and cell therapies.

The Biotech Showcase 2018 will take place at the Hilton San Francisco Union Square located at 333 O’Farrell Street – Ballroom Level, San Francisco, California 94102